In 2013 , the FDA approved the drug in three formulations : as a stand - alone with the brand - name Nesina , combined with metformin using the name Kazano .
In 2013 , the FDA when combined with pioglitazone as Oseni .
In 2013 , the FDA approved the drug in three formulations : as a stand - alone with the brand - name Nesina , combined with metformin using the name Kazano , and when combined with pioglitazone as Oseni .